Association Between Performance Measures and Glycemic Control Among Patients With Diabetes in a Community-wide Primary Care Cohort.

BACKGROUND: : Performance measures are used for assessing quality of care. Higher performance shown by these measures is expected to reflect better care, but little is known whether they predict better patient outcomes. OBJECTIVE: : To assess the predictive value of performance measures of glucose m...

Descripción completa

Detalles Bibliográficos
Publicado en:Medical Care Vol. 51; no. 2; pp. 172 - 180
Autores principales: Sidorenkov G, Voorham J, Haaijer-Ruskamp FM, de Zeeuw D, Denig P
Formato: research Journal Article
Publicado: Lippincott Williams & Wilkins 2013 Feb
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108019214&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 108019214
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00257079
        21B
      jtl: Medical Care
      issn: 00257079
      maglogo: N
    pubinfo:
      dt: 2013 Feb
      vid: 51
      iid: 2
      pid: 433
      pub: Lippincott Williams & Wilkins
      place: Baltimore, Maryland
    artinfo:
      ui:
        108019214
        108019214
        2011900960
        10.1097/MLR.0b013e318277eaf5
        NLM23222526
        108019214
      ppf: 172
      ppct: 8
      formats:
      tig:
        atl: Association Between Performance Measures and Glycemic Control Among Patients With Diabetes in a Community-wide Primary Care Cohort.
      aug:
        au:
          Sidorenkov G
          Voorham J
          Haaijer-Ruskamp FM
          de Zeeuw D
          Denig P
        affil: Department of Clinical Pharmacology tResearch Institute SHARE of the Graduate School of Medical Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
      sug:
        subj:
          Diabetes Mellitus, Type 2 Therapy
          Outcomes (Health Care)
          Primary Health Care
          Quality of Health Care
          Aged
          Biological Markers Blood
          Blood Glucose Analysis
          Prospective Studies
          Comorbidity
          Diabetes Mellitus, Type 2 Epidemiology
          Disease Management
          Female
          Glycated Hemoglobin Analysis
          Human
          Linear Regression
          Male
          Netherlands
          Predictive Value of Tests
          Aged: 65+ years
          Female
          Male
      ab: BACKGROUND: : Performance measures are used for assessing quality of care. Higher performance shown by these measures is expected to reflect better care, but little is known whether they predict better patient outcomes. OBJECTIVE: : To assess the predictive value of performance measures of glucose management on glycemic control, and evaluate the impact of patient characteristics on this association. RESEARCH DESIGN: : Cohort study (2007-2009). SUBJECTS: : A total of 15,454 type 2 diabetes patients (mean age, 66.5 y; 48% male) from the GIANTT cohort. MEASURES: : We included performance measures assessing frequency of HbA1c monitoring, glucose-lowering treatment status, and treatment intensification. Associations between performance and glycemic control were tested using multivariate linear regression adjusted for confounding, reporting estimated differences in HbA1c with 95% confidence intervals (CI). Impact of patient characteristics was examined through interactions. RESULTS: : Annual HbA1c monitoring was associated with better glycemic control when compared with no such monitoring (HbA1c -0.29%; 95% CI -0.37, -0.22). This association lost significance in patients with lower baseline HbA1c, older age, and without macrovascular comorbidity. Treatment status was associated with better glycemic control only in patients with elevated baseline HbA1c. Treatment intensification after elevated HbA1c levels was associated with better glycemic control compared with no intensification (HbA1c -0.21; 95% CI -0.26, -0.16). CONCLUSIONS: : Performance measures of annual HbA1c monitoring and of treatment intensification did predict better patient outcomes, whereas the measure of treatment status did not. Predictive value of annual monitoring and of treatment status varied across patient characteristics, and it should be used with caution when patient characteristics cannot be taken into account.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N